Category: <span>Peptide Boundaries</span>

One of the easiest credibility wins in this entire section is simply saying this clearly: NAD is not a peptide. That correction matters because once a brand gets the category wrong, selective readers stop trusting the rest of the explanation. Why the confusion happens NAD often gets pulled into the same conversation because women hear […]

GLP-1 belongs in the peptide guide because beauty audiences are already hearing about it through body-image, aging, wellness, and aesthetics conversations. But it should never be treated like a playful beauty shortcut or a normal skincare topic. Why this topic shows up in beauty spaces Women are seeing GLP-1 discussed through visible body change, appetite, […]

MOTS-c attracts attention because it sits near the topics women care about most right now: metabolism, energy, healthy aging, and physical resilience. But being interesting is not the same thing as being ready for a casual consumer beauty conversation. Why the topic spreads so quickly Anything that sounds like it might touch energy, metabolism, body […]

BPC-157 is one of those topics women keep hearing about even when they are not actively researching peptides. That is exactly why it needs disciplined framing. Curiosity is real. Confidence should still be limited. Why beauty audiences keep hearing about it The online conversation around BPC-157 tends to spill across recovery, performance, wellness, and “healing” […]

The best way to protect yourself in a peptide conversation is to stop asking only, “Does this sound exciting?” and start asking, “What category is this really in, and how much certainty has actually been earned?” The first five questions to ask Is this topical beauty, investigational territory, or prescription medicine? Is the category being […]